MG

Marc De Garidel

Chairman at Ipsen

Marc de Garidel is a graduate from the French Engineering School ESTP and has an Executive MBA from Harvard Business School.

Marc de Garidel started his career with Eli Lilly with various responsibilities in countries like US, Germany, France. Between 1995 and 2010, he held Executive position in finance & general management including the biggest region of Amgen International operations & the corporate controller of Amgen Inc.

Marc de Garidel joined Ipsen as Chairman and CEO in November 2010.

He is now Chairman of the Board of Directors of Ipsen since the third quarter of 2016 and is advisor of the Ipsen holding company Mayroy SA.

Marc de Garidel has been CEO of Corvidia Therapeutics, Inc. since March 29, 2018.

Org chart

HB

Henri Beaufour

Director

AF

Antoine Flochel

Vice Chairman

ML

Margaret Liu

Director

PW

Piet Wigerinck

Director

NB

Naomi Binoche

Director

AB

Anne Beaufour

Director

PB

Philippe Bonhomme

Director

LD

Laetitia Ducroquet

Director

Teams

AF
HB
MG
+1

Board of Directors

4 members

Timeline

  • Chairman

    Current role